Dr. David A. Dawson

Dr. David A. Dawson is a biomolecular psychologist and the founder of AMCANN Research, where he leads investigations into the quantitative characterization of the endocannabinoid system as a measurable component of human physiology.

His work focuses on developing analytical and diagnostic frameworks to evaluate endogenous cannabinoid signaling, with particular emphasis on biomarker identification, population-level reference modeling, and translational application. Integrating principles from molecular biology, psychopharmacology, and psychoneuroimmunology, his research is directed toward establishing clinically interpretable measures of endocannabinoid function.

At AMCANN Research, Dr. Dawson oversees programs spanning endocannabinoid quantification, analytical method development, disorder identification, and intervention modeling. These initiatives are structured to support a continuous translational pipeline in which laboratory measurements inform diagnostic criteria and therapeutic strategies. His work contributes to the broader objective of defining the endocannabinoid system as a system suitable for objective clinical evaluation, comparable to established endocrine and metabolic frameworks.

For additional professional background, please visit: https://dawsonphd.com/